Company & Sponsor Intelligence

Hadassah Medical Organization

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials8

Recruiting0

Completed7

Countries1

Therapeutic footprint

adhdautismmultiple_sclerosisptsd

Indexed studies

NCT01686685Correlation of CXCR4 Expression in Premature Infants With a Diagnosis of Autism at 24 Months
autism · IsraelCOMPLETED

NCT00646464New Continuous Performance Tests (CPT) for the Diagnosis of Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
adhd · IsraelCOMPLETED

NCT03361787A Multi-dimensional Program for Parents of Adolescents With High-functioning Autism
autism · IsraelNA

NCT01448252T Cell Vaccination in Patients With Progressive Multiple Sclerosis
multiple_sclerosis · IsraelPHASE1, PHASE2

NCT00843141The Efficacy of Computerized Cognitive Training in Adults With ADHD: Change in ADHD Symptoms, Executive Functions and Quality of Life Following Three Months of Training.
adhd · IsraelNA

NCT02681575Meta-cognitive Functional Intervention for Adults With ADHD: A Pilot Efficacy Study
adhd · IsraelNA

NCT00146900Prevention of Post Traumatic Stress Disorder by Early Treatment
ptsd · IsraelNA

NCT00318162Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)
autism · IsraelPHASE1, PHASE2

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →